Re: Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Allen D
AD
Seftel
D020249:Hormone Replacement Therapy; D006801:Humans; D007006:Hypogonadism / Q000097:blood* / Q000188:drug therapy*; D008297:Male; D011467:Prostate / Q000378:metabolism*; D017430:Prostate-Specific Antigen; D013739:Testosterone / Q000627:therapeutic use*
D013739:Testosterone; D017430:Prostate-Specific Antigen